Literature DB >> 17043799

Differential proteome analysis of colon carcinoma cell line SW480 after reconstitution of the tumour suppressor Smad4.

Kai Stühler1, Katharina Köper, Kathy Pfeiffer, Andreas Tagariello, Manfred Souquet, Irmgard Schwarte-Waldhoff, Stephan A Hahn, Wolff Schmiegel, Helmut E Meyer.   

Abstract

The tumour suppressor gene Smad4 is frequently inactivated in gastrointestinal carcinomas. Smad4 plays a pivotal role in transducing signals of the transforming growth factor-beta (TGF-beta) superfamily of proteins. Inactivation of Smad4 seems to occur late during tumour progression when tumours acquire invasive and metastatic properties. Identification of proteins directly or indirectly regulated by Smad4 would, therefore, ease the future design of new diagnostic and therapeutic strategies for gastrointestinal carcinoma. We have used human colon carcinoma cell line SW480 stably transfected with Smad4 as an in-vitro model system to identify Smad4-regulated proteins by applying two-dimensional gel electrophoresis (2DE) then MALDI-PMF/PFF-MS. We identified a total of 47 protein species with a Smad4-dependent expression. From the functions of the candidate proteins we obtained new insights into Smad4's participation in processes, for example apoptosis, differentiation, and proliferation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043799     DOI: 10.1007/s00216-006-0803-9

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  3 in total

1.  Phosphoprotein Keratin 23 accumulates in MSS but not MSI colon cancers in vivo and impacts viability and proliferation in vitro.

Authors:  Karin Birkenkamp-Demtroder; Francisco Mansilla; Flemming Brandt Sørensen; Mogens Kruhøffer; Teresa Cabezón; Lise Lotte Christensen; Lauri A Aaltonen; Hein W Verspaget; Torben Falck Ørntoft
Journal:  Mol Oncol       Date:  2007-06-03       Impact factor: 6.603

2.  Repression of KIAA1199 attenuates Wnt-signalling and decreases the proliferation of colon cancer cells.

Authors:  K Birkenkamp-Demtroder; A Maghnouj; F Mansilla; K Thorsen; C L Andersen; B Øster; S Hahn; T F Ørntoft
Journal:  Br J Cancer       Date:  2011-07-19       Impact factor: 7.640

Review 3.  Roles of Smads Family and Alternative Splicing Variants of Smad4 in Different Cancers.

Authors:  Irfan Ullah; Weichao Sun; Liling Tang; Jianguo Feng
Journal:  J Cancer       Date:  2018-10-16       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.